Transcatheter Pulmonary Valve Devices Market: By Type, By Application, By End User and Geography

Transcatheter Pulmonary Valve (TPV) Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Balloon-Expanded, Self-Expanded), By Application (Cardiac Anomaly, Pulmonary Atresia, Pulmonary Stenosis, Pulmonary Regurgitation, Tetralogy of Fallot, Truncus Arteriosus, and Others), By End User (Public Sector and Private Sector) and Region

Transcatheter Pulmonary Valve (TPV) Devices Market size was valued at US$ 80.85 million in 2023 and is projected to a reach a value of US$ 118.4 million by 2030, at a CAGR of 5.6% from 2024-2030. The market is experiencing significant growth, driven by several factors such as rising cases of several cardiovascular diseases, technological advancements, increasing demand for minimally invasive procedures, and a growing geriatric population. The rising incidences of many forms of cardiovascular diseases, such as rheumatic heart disorders, hypertensive heart diseases, cerebrovascular diseases, and inflammatory heart diseases. CVDs are responsible for 17.9 million deaths every year, according to the reports of WHO. This accounts for about 32% of all deaths worldwide. Over three-quarters of these CVD deaths occur in low- and middle-income countries.

Further, 17 million premature deaths—before the age of 70 years—due to noncommunicable diseases alone in 2019, 38% were because of CVDs. Very few of the other key factors likely to drive the industry are technological advancements in valve replacement procedures. A few primary reasons that indicate its surging demand and adoption rate amongst the patient population include an increasing number of product launches that are related to transcatheter heart valve technologies. The high cost of devices and procedures, reimbursement issues, and limited long-term data are the constraints, that are hindering market growth. Growing awareness, expansion into emerging markets, focus on innovation, ambulatory TPV procedures, and remote monitoring are the recent trends and opportunities in the transcatheter pulmonary valve (TPV) devices market.

Transcatheter Pulmonary Valve (TPV) Devices Market Key Developments:

  • In May 2022, VenusP-Valve™, an innovative transcatheter pulmonic valve replacement (TPVR) system developed by Venus Medtech, has gained FDA approval for compassionate use in two cases. This approval underscores its unique clinical value even before formal clinical trials.
  • In March 2021, the Harmony Transcatheter Pulmonary Valve from Medtronic plc received U.S. FDA approval as the first minimally invasive therapy designed to treat patients with a specific type of congenital heart defect of the right ventricle—one of the four chambers of the heart, which makes blood travel hard from it to the lungs.

Transcatheter Pulmonary Valve (TPV) Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Transcatheter Pulmonary Valve (TPV) Devices Market Dynamics

Some major drivers for this market include increasing congenital heart disease burden and rising awareness of transcatheter pulmonary valve therapy. Increasing product development and launch by companies along with rising approval of products, the market growth is anticipated to further augment during the forecast period. For instance, according to the CDC, in February 2022, Congenital heart disease (CHD) relates to nearly 1% of or about 40,000 births per year in the United States. Secondly, 15% of CHDs are related to genetic conditions, and approximately 20% to 30% with a CHD have other physical problems or developmental or cognitive disorders. Children with CHD are at an approximate 50 percent higher chance of receiving special education services as compared to children in whom birth defects were not observed. Therefore, it can be contested that an increasing burden of CHD will increase the growth of the studied market. 

Transcatheter Pulmonary Valve (TPV) Devices Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 80.85 million

Market Size in 2030

US$ 118.4 million

Market CAGR

5.6%

By Type

  • Balloon-Expanded
  • Self-Expanded

By Application

  • Cardiac Anomaly
  • Pulmonary Atresia
  • Pulmonary Stenosis
  • Pulmonary Regurgitation
  • Tetralogy of Fallot
  • Truncus Arteriosus
  • Others

By End User

  • Private Hospital
  • Public Hospitals

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

The transcatheter pulmonary valve (TPV) devices market was valued at US$ 80.85 million in 2023 and is projected to grow at 5.6% CAGR over the forecast years to reach US$ 118.4

• Cardiovascular diseases
• Technological advancements
• Increasing demand for minimally invasive procedures
• A growing geriatric population

• High cost of devices and procedures
• Reimbursement issues
• Limited long-term data

• Growing awareness
• Expansion into emerging markets
• Focus on innovation
• Ambulatory TPV procedures
• Remote monitoring

Asia-Pacific is the fastest-growing region in the transcatheter pulmonary valve (TPV) devices market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Transcatheter Pulmonary Valve Devices Market Introduction 
2.1.Global Transcatheter Pulmonary Valve Devices Market  - Taxonomy
2.2.Global Transcatheter Pulmonary Valve Devices Market  - Definitions
2.2.1.Type 
2.2.2.Application
2.2.3.End Users
2.2.4.Region
3.Global Transcatheter Pulmonary Valve Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Transcatheter Pulmonary Valve Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Transcatheter Pulmonary Valve Devices Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Balloon-Expanded
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Self-Expanded
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Transcatheter Pulmonary Valve Devices Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Cardiac Anomaly
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Pulmonary Atresia
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Pulmonary Stenosis
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Pulmonary Regurgitation
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Tetralogy of Fallot
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Truncus Arteriosus
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global Transcatheter Pulmonary Valve Devices Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Private Hospital
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Public Hospitals
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Transcatheter Pulmonary Valve Devices Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Transcatheter Pulmonary Valve Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Balloon-Expanded
9.1.2.Self-Expanded
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Cardiac Anomaly
9.2.2.Pulmonary Atresia
9.2.3.Pulmonary Stenosis
9.2.4.Pulmonary Regurgitation
9.2.5.Tetralogy of Fallot
9.2.6.Truncus Arteriosus
9.2.7.Others
9.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Private Hospital
9.3.2.Public Hospitals
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Transcatheter Pulmonary Valve Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Balloon-Expanded
10.1.2.Self-Expanded
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cardiac Anomaly
10.2.2.Pulmonary Atresia
10.2.3.Pulmonary Stenosis
10.2.4.Pulmonary Regurgitation
10.2.5.Tetralogy of Fallot
10.2.6.Truncus Arteriosus
10.2.7.Others
10.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Private Hospital
10.3.2.Public Hospitals
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Transcatheter Pulmonary Valve Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Balloon-Expanded
11.1.2.Self-Expanded
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cardiac Anomaly
11.2.2.Pulmonary Atresia
11.2.3.Pulmonary Stenosis
11.2.4.Pulmonary Regurgitation
11.2.5.Tetralogy of Fallot
11.2.6.Truncus Arteriosus
11.2.7.Others
11.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Private Hospital
11.3.2.Public Hospitals
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Transcatheter Pulmonary Valve Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Balloon-Expanded
12.1.2.Self-Expanded
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cardiac Anomaly
12.2.2.Pulmonary Atresia
12.2.3.Pulmonary Stenosis
12.2.4.Pulmonary Regurgitation
12.2.5.Tetralogy of Fallot
12.2.6.Truncus Arteriosus
12.2.7.Others
12.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Private Hospital
12.3.2.Public Hospitals
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Transcatheter Pulmonary Valve Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Balloon-Expanded
13.1.2.Self-Expanded
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cardiac Anomaly
13.2.2.Pulmonary Atresia
13.2.3.Pulmonary Stenosis
13.2.4.Pulmonary Regurgitation
13.2.5.Tetralogy of Fallot
13.2.6.Truncus Arteriosus
13.2.7.Others
13.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Private Hospital
13.3.2.Public Hospitals
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Boston Scientific Corporation
14.2.2.Braile Biomedica, Direct Flow Medical, Inc
14.2.3.Edward Lifesciences Corporation
14.2.4.JenaValve Technology, Inc
14.2.5.Medtronic
14.2.6.Jude Medical
14.2.7.SYMETIS SA
14.2.8.Xeltis
14.2.9.Venus Medtech
14.2.10.LivaNova PLC
14.2.11.Cryolife, Inc
14.2.12.Colibri Heart Valve, LLC
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Boston Scientific Corporation
  • Braile Biomedica, Direct Flow Medical, Inc
  • Edward Lifesciences Corporation
  • JenaValve Technology, Inc
  • Medtronic
  • Jude Medical
  • SYMETIS SA
  • Xeltis
  • Venus Medtech
  • LivaNova PLC
  • Cryolife, Inc
  • Colibri Heart Valve, LLC

Related Industry Reports